Abstract: The present invention is to provide a medical composition for the treatment or prophylaxis of diseases caused by angiogenesis of eyes which comprises a compound represented by the following formula (I): wherein R1 represents a C1-C6 alkyl group or halogeno-C1-C6 alkyl group, R2 represents a carboxyl group which may be protected, and Y represents a group represented by the formula (II): wherein Z represents CH or nitrogen atom, or a pharmaceutically acceptable salt thereof as an active ingredient.
NA
| # | Name | Date |
|---|---|---|
| 1 | 8098-delnp-2011-Others-(09-12-2011).pdf | 2011-12-09 |
| 2 | 8098-delnp-2011-GPA-(09-12-2011).pdf | 2011-12-09 |
| 3 | 8098-delnp-2011-Correspondence Others-(09-12-2011).pdf | 2011-12-09 |
| 4 | 8098-delnp-2011-Assignment-(09-12-2011).pdf | 2011-12-09 |
| 5 | 8098-delnp-2011-Form-5.pdf | 2012-04-03 |
| 6 | 8098-delnp-2011-Form-3.pdf | 2012-04-03 |
| 7 | 8098-delnp-2011-Form-2.pdf | 2012-04-03 |
| 8 | 8098-delnp-2011-Form-1.pdf | 2012-04-03 |
| 9 | 8098-delnp-2011-Drawings.pdf | 2012-04-03 |
| 10 | 8098-delnp-2011-Description (Complete).pdf | 2012-04-03 |
| 11 | 8098-delnp-2011-Correspondence Others.pdf | 2012-04-03 |
| 12 | 8098-delnp-2011-Claims.pdf | 2012-04-03 |
| 13 | 8098-delnp-2011-Abstract.pdf | 2012-04-03 |
| 14 | 8098-delnp-2011-Form-3-(11-04-2012).pdf | 2012-04-11 |
| 15 | 8098-delnp-2011-Correspondence-Others-(11-04-2012).pdf | 2012-04-11 |
| 16 | 8098-delnp-2011-Form-18-(19-03-2013).pdf | 2013-03-19 |
| 17 | 8098-delnp-2011-Correspondence-Others-(19-03-2013).pdf | 2013-03-19 |
| 18 | 8098-DELNP-2011-FER.pdf | 2017-07-19 |
| 19 | 8098-DELNP-2011-AbandonedLetter.pdf | 2018-01-30 |
| 1 | 8098delnp2011searchstrategy_19-07-2017.pdf |